Loading
Loading…
Loading…
Ref. No.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | RA Ended | 1 | ₹2,100 |
| 2 | Schedule 2 | GOYAL MEDICAL & GENERAL AGENCYLikely | RA Ended | 4 | ₹7,800 |
| 3 | Schedule 3 | SRI SAI AGENCIESLikely | RA Ended | 1 | ₹45,097.50 |
| 4 | Schedule 4 | MAMMOTH LIFESCIENCES LLPLikely | RA Ended | 1 | ₹2.2 L |
| 5 | Schedule 6 | SONDHI SONS PHARMALikely | RA Ended | 1 | ₹23,861.25 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
26 Mar 2026, 10:00 amClosed
DGLP RE 221 MED OPD AND URO OPD
9047458
GEM/2026/B/7293168
Two Packet Bid
TAB SILDENAFIL 25 MG,TAB TOLTERODINE TARTATE 2 MG,FOSFOMYCIN 3 MG SACHET,TAB ENZALUTAMIDE 80 MG,TAB
Jalandhar, Punjab
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹3 L
₹16 L
80%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| TAB SILDENAFIL 25 MG | - | 16,965 | - |
OIC DGLP, Military Hospital Jalandhar, Department of Military Affairs, Indian Army, Ministry of Defence, (Nagendra Singh Beniwal)
Exempted
Yes
8 Mar 2026
8 Mar 2026
26 Mar 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9047458.pdf
GEM_BID
ATC_38ece3c0-259a-4118-a47c1772078890078_LP_MHJRC.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
croped_docu_2026-02-26-09-32-32_db22489419db9c61d95ed2c8c6fc6ad9.pdf
BOQ
boq_item_sample_file_2026-02-26-09-32-32_66c42d86fb1f74f3572fd9e41ab27577.csv.pdf
BOQ
ATC_38ece3c0-259a-4118-a47c1772078890078_LP_MHJRC.docx
GEM_OTHER • 0.01 MB
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .